-
Koren's hanging up! Take 15 heavy-weight varieties, 36 over-rated varieties bright eyes, 11 new class 1 drugs, 41 new products on the road
Time of Update: 2021-03-04
Entering 2021, The Colum Pharmaceuticals product line continues to be happy news, 2 injections have been evaluated, 4 injections were approved at that time. just past 2020, Colum Pharmaceuticals has had a lot of gains: 15 varieties have been
-
Increased inventory The central bank cut interest rates also difficult to pull the real estate adjustment trend
Time of Update: 2021-03-04
institutions adjust the structure, increase support for small micro-enterprises, "three rural" and major water conservancy projects. In fact, real estate companies are also cheering the rate cut, which seems to be the best for the industry to bear the burden
-
The treatment of non-small cell lung cancer energizer KRAS inhibitors reached 80.6% disease control rate
Time of Update: 2021-03-03
Today, Amgen announced the latest results from a critical Phase 2 clinical trial in patients with advanced non-small cell lung cancer (NSCLC) who studied the KRAS G12C inhibitor sotorasib (AMG 510).
-
3% success rate of telephone sales, how to achieve a 30% growth rate?
Time of Update: 2021-03-03
T company to expand the third and fourth-line dealers, and not as simple as other manufacturers to sign agents, distribution agreements, furniture to you regardless, they take dealers as their own team to train.
-
The older the parents, the higher the rate of spontaneous genetic mutations in children
Time of Update: 2021-03-03
researchers say the latest analysis helps to understand the mutation processes that cause the diversity of human genome sequences, which are critical in medical, genetic and evolutionary chemistry studies.
-
Five-year survival rate of 81.4% for two-year patients treated with NSCLC on the first line of Keytruda in Meshadon
Time of Update: 2021-03-02
The results showed that in patients with metastasis NSCLC with tumor expression PD-L1 (TPS≥50%) and no EGFR or ALC genomic tumor distortion, Keytruda first-line therapy showed long-lasting long-term survival benefits and long-lasting response compared to chemotherapy.
-
Fujian Province building materials quality sampling pass rate of less than 90%.
Time of Update: 2021-03-01
Provincial Quality Supervision Bureau said that from the year-round spot checks, our province daily ceramics, children's toys, lamps, composite (mixed) fertilizer, food packaging materials and other 142 kinds of products pass rate of more than 95%;
-
The national insurance participation rate has been about 97%!
Time of Update: 2021-03-01
medical insurance system; Effectively curbed the trend of inflated drug prices, sent a clear signal to enhance the mutual assistance function of the medical insurance system by canceling the individual account of the residents' medical insurance
-
Among the five categories of products, the pass rate of building materials sampling is less than 90%.
Time of Update: 2021-03-01
Provincial Quality Supervision Bureau said that from the year-round spot checks, our province daily ceramics, children's toys, lamps, composite (mixed) fertilizer, food packaging materials and other 142 kinds of products pass rate of more than 95%;
-
The decline in research and development power of pharmaceutical giants has slowed the growth rate of the number of research and development enterprises
Time of Update: 2021-02-28
In 2018, when Big Mac mergers and acquisitions activity declined, followed by a decline in the number of products under development, only six of top25 pharmaceutical companies are studying an unprecedented increase in the number of drugs.
-
Wan Jianmin: The contribution rate of agricultural science and technology to food security
Time of Update: 2021-02-28
Jing, a professor at the Institute of Agricultural Quality Standards and Testing Technology at the Chinese Academy of Agricultural Sciences, said safe agricultural products were both "produced" and "piped".
-
Estimation of Chronological Age from the Racemization Rate of l- and d-Aspartic Acid: How to Completely Separate Enantiomers from Dentin
Time of Update: 2021-02-27
We describe the detailed procedures and the critical points for obtaining reliable estimated ages using the racemization method.
-
Nature Communications: What's new! The rate of asymmetry in the left and right brains may indicate a risk of Alzheimer's disease
Time of Update: 2021-02-26
as we age and time, the cerebral cortical becomes thinner and the symmetry of the thickness of the cortical body changes, so the function of the brain decreases.
-
Br J Cancer: Analysis of survival rates in breast cancer patients with BRCA2 mutations
Time of Update: 2021-02-26
previous studies have shown that most breast cancers associated with BRCA2 mutations show ER-positive, while ER-positive is a favorable prognostic factor compared to ER-negative in the general early-stage patient population.
-
Central Bank: cut mortgage rates and the down payment ratio of second homes has been documented
Time of Update: 2021-02-26
to buy the down payment ratio of the first home to 20%; The document has now been supported by the Ministry of Finance and the Central Bank in fact, support for the use of provident funds to reduce the down payment ratio of measures, local governments
-
Mouse survival rate increased from 0 to 100% within 50 days of tumor elimination in 10 minutes
Time of Update: 2021-02-25
Nanodrives for cancer treatment have been widely used in preclinical and clinical applications, especially with phototherapy methods, to target tumors precisely and minimize damage to normal cells.
-
Nat Med: A summary analysis of pathological response and survival rates of new complementary therapies for melanoma
Time of Update: 2021-02-25
in patients with stage IV melanoma, immunotherapy based on anti-PD-1 and BRAF/MEK combined target therapies had higher response rates and improved overall survival (OS).
-
AstraZeneia's Imfinzi failed to improve the overall survival rate of patients with head and neck cancer
Time of Update: 2021-02-24
In the second trial, AstraZeneca's Imfinzi failed to improve the overall survival of patients with relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) (OS). update to Imfinzi's KESTREL PHASE III clinical trial found
-
Drug Ming Juno will announce the best total remission rate of 75.9% for phase 2 clinical results of CAR-T therapy
Time of Update: 2021-02-24
of the Relma-cel Clinical Trial Phase II will be presented at the 62nd ANNUAL ASH Conference. Retrieved Nov 16,2020, from [2] 1186 Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory （r/r） Large B-Cell Lymphoma in China . From Source: Medical Mission Hills
-
Nature In-depth Report: What is the reason why the global new crown mortality rate is declining?
Time of Update: 2021-02-24
, a large-scale study exploring a variety of new coronary therapies, published in June in the UK's RECOVERY clinical trial, showed that hydroxychloroquine did not improve the mortality rate in COVID-19 hospitalizations.
